Two weeks after the treatment, the cRLN1 encoding murine relaxin significantly reduced the liver fibrosis as judged by the brightness area in ultrasound reflections (∼3-fold) and also restored the elevated AST and ALT levels back to normal. The gene discussed is GPT; the disease is Hepatic fibrosis.